87 related articles for article (PubMed ID: 25075024)
41. N-benzoylated phenoxazines and phenothiazines: synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
Prinz H; Chamasmani B; Vogel K; Böhm KJ; Aicher B; Gerlach M; Günther EG; Amon P; Ivanov I; Müller K
J Med Chem; 2011 Jun; 54(12):4247-63. PubMed ID: 21563750
[TBL] [Abstract][Full Text] [Related]
42. N-(2,6-dimethoxypyridine-3-yl)-9-methylcarbazole-3-sulfonamide as a novel tubulin ligand against human cancer.
Wang YM; Hu LX; Liu ZM; You XF; Zhang SH; Qu JR; Li ZR; Li Y; Kong WJ; He HW; Shao RG; Zhang LR; Peng ZG; Boykin DW; Jiang JD
Clin Cancer Res; 2008 Oct; 14(19):6218-27. PubMed ID: 18829501
[TBL] [Abstract][Full Text] [Related]
43. JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs.
Kong D; Yamori T
Bioorg Med Chem; 2012 Mar; 20(6):1947-51. PubMed ID: 22336246
[TBL] [Abstract][Full Text] [Related]
44. Discovery and structure-activity relationships of (2-(arylthio)benzylideneamino)guanidines as a novel series of potent apoptosis inducers.
Zhang HZ; Crogan-Grundy C; May C; Drewe J; Tseng B; Cai SX
Bioorg Med Chem; 2009 Apr; 17(7):2852-8. PubMed ID: 19282188
[TBL] [Abstract][Full Text] [Related]
45. Antitumor agents. 178. Synthesis and biological evaluation of substituted 2-aryl-1,8-naphthyridin-4(1H)-ones as antitumor agents that inhibit tubulin polymerization.
Chen K; Kuo SC; Hsieh MC; Mauger A; Lin CM; Hamel E; Lee KH
J Med Chem; 1997 Sep; 40(19):3049-56. PubMed ID: 9301667
[TBL] [Abstract][Full Text] [Related]
46. Tubulin inhibitor AEZS 112 inhibits the growth of experimental human ovarian and endometrial cancers irrespective of caspase inhibition.
Engel JB; Schönhals T; Weidler C; Häusler S; Krockenberger M; Rieger L; Dietl J; Wischhusen J; Honig A
Oncol Rep; 2009 Aug; 22(2):361-7. PubMed ID: 19578778
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and anticancer activity of analogues of phenstatin, with a phenothiazine A-ring, as a new class of microtubule-targeting agents.
Abuhaie CM; Bîcu E; Rigo B; Gautret P; Belei D; Farce A; Dubois J; Ghinet A
Bioorg Med Chem Lett; 2013 Jan; 23(1):147-52. PubMed ID: 23200248
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and biological evaluation of 1-(4'-Indolyl and 6'-Quinolinyl) indoles as a new class of potent anticancer agents.
Lai MJ; Chang JY; Lee HY; Kuo CC; Lin MH; Hsieh HP; Chang CY; Wu JS; Wu SY; Shey KS; Liou JP
Eur J Med Chem; 2011 Sep; 46(9):3623-9. PubMed ID: 21641700
[TBL] [Abstract][Full Text] [Related]
49. Benzothiazoles: search for anticancer agents.
Noolvi MN; Patel HM; Kaur M
Eur J Med Chem; 2012 Aug; 54():447-62. PubMed ID: 22703845
[TBL] [Abstract][Full Text] [Related]
50. Phenylimino-10H-anthracen-9-ones as novel antimicrotubule agents-synthesis, antiproliferative activity and inhibition of tubulin polymerization.
Prinz H; Schmidt P; Böhm KJ; Baasner S; Müller K; Gerlach M; Günther EG; Unger E
Bioorg Med Chem; 2011 Jul; 19(14):4183-91. PubMed ID: 21705223
[TBL] [Abstract][Full Text] [Related]
51. Novel diarylsulfonylurea derivatives as potent antimitotic agents.
Kim S; Park JH; Koo SY; Kim JI; Kim MH; Kim JE; Jo K; Choi HG; Lee SB; Jung SH
Bioorg Med Chem Lett; 2004 Dec; 14(24):6075-8. PubMed ID: 15546733
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and antitumor activities of novel α-aminophosphonates dehydroabietic acid derivatives.
Huang XC; Wang M; Pan YM; Tian XY; Wang HS; Zhang Y
Bioorg Med Chem Lett; 2013 Oct; 23(19):5283-9. PubMed ID: 23988357
[TBL] [Abstract][Full Text] [Related]
53. Design, synthesis and biological evaluation of millepachine derivatives as a new class of tubulin polymerization inhibitors.
Wang G; Peng F; Cao D; Yang Z; Han X; Liu J; Wu W; He L; Ma L; Chen J; Sang Y; Xiang M; Peng A; Wei Y; Chen L
Bioorg Med Chem; 2013 Nov; 21(21):6844-54. PubMed ID: 23993668
[TBL] [Abstract][Full Text] [Related]
54. Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways.
Chen YC; Lu PH; Pan SL; Teng CM; Kuo SC; Lin TP; Ho YF; Huang YC; Guh JH
Biochem Pharmacol; 2007 Jun; 74(1):10-9. PubMed ID: 17475221
[TBL] [Abstract][Full Text] [Related]
55. Discovery of novel 2-N-aryl-substituted benzenesulfonamidoacetamides: orally bioavailable tubulin polymerization inhibitors with marked antitumor activities.
Liu Z; Zhou Z; Tian W; Fan X; Xue D; Yu L; Yu Q; Long YQ
ChemMedChem; 2012 Apr; 7(4):680-93. PubMed ID: 22311585
[TBL] [Abstract][Full Text] [Related]
56. Antiproliferative Activity Predictor: A New Reliable In Silico Tool for Drug Response Prediction against NCI60 Panel.
Martorana A; La Monica G; Bono A; Mannino S; Buscemi S; Palumbo Piccionello A; Gentile C; Lauria A; Peri D
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430850
[TBL] [Abstract][Full Text] [Related]
57. Analysis of Food and Drug Administration-approved anticancer agents in the NCI60 panel of human tumor cell lines.
Holbeck SL; Collins JM; Doroshow JH
Mol Cancer Ther; 2010 May; 9(5):1451-60. PubMed ID: 20442306
[TBL] [Abstract][Full Text] [Related]
58. Synthesis, characterization of novel N-(4-cyano-1,3-oxazol-5-yl)sulfonamide derivatives and in vitro screening their activity against NCI-60 cancer cell lines.
Severin O; Pilyo S; Kachaeva M; Zhirnov V; Hodyna D; Bahrieieva O; Brovarets V
ChemMedChem; 2024 Mar; 19(5):e202300527. PubMed ID: 38241069
[TBL] [Abstract][Full Text] [Related]
59. Development of MBRI-001, a deuterium-substituted plinabulin derivative as a potent anti-cancer agent.
Ding Z; Cheng H; Wang S; Hou Y; Zhao J; Guan H; Li W
Bioorg Med Chem Lett; 2017 Mar; 27(6):1416-1419. PubMed ID: 28228362
[TBL] [Abstract][Full Text] [Related]
60. Synthesis of Potent Cytotoxic Epidithiodiketopiperazines Designed for Derivatization.
Olsson CR; Payette JN; Cheah JH; Movassaghi M
J Org Chem; 2020 Apr; 85(7):4648-4662. PubMed ID: 32126173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
